Recently, Hyderabad-based pharmaceutical company Lee Pharma (herein after as “the applicant”) filed a Compulsory License (CL) Application for AstraZeneca’s diabetes management drug Saxagliptin. […]
The battle for another CL initiates in India
Patent
Ericsson v Micromax: The fire that won’t die out easily
Authored by Neharika Nainta, Senior Associate at LexOrbis. She is associated with the LexOrbis’s Litigation and Enforcement group and has been dealing with […]
No Patent for ‘Aquasure’
The post is co-authored by Ms. Zoya Nafis, LexOrbis Associate and Mr. Abhigyan Ashok, final year student of BBA.LL.B from Faculty of Law, […]
Early Patent Protection Route for SMEs and Start-ups
Once an inventive idea strikes you, you start putting all your resources together to create a prototype. What if, while solving the same […]
Pudin Hara takes the sting out of infringement allegations
In a detailed interim order, the Delhi High Court has validated Dabur’s Pudin Hara Lemon Fizz Advertisement against infringement/passing off allegations by England […]
India finally realizes the importance of Khadi
We brought to your notice in our earlier post dated November 8 about India’s determination to protect brand ‘Khadi’. Pursuant to this, the […]
Monopolizing Traditional Knowledge- Turmeric Extract gets patent in USA
A Kerala based company, Arjuna Natural Extracts Ltd has received a US patent for turmeric extract formulation BCM 95. BCM 95 is a […]
Hard Times for Ranbaxy: Indian Generic maker stripped of approval by USFDA
In a major blow to the Indian pharmaceutical company, US Food and Drug Administrator (FDA) told Ranbaxy earlier this month that it had […]
78% Of The Patent Filings In India By Non-Residents
Non-residents filed 78.3 per cent of the total number of patent applications in India in the year 2012, as per the latest data […]
Important Ruling on Section 8 of the Patents Act, 1970
A notable ruling has come from Delhi High Court on revocation of patents. Section 8 of the India Patents Act, 1970 (the “Act”) […]